发明名称 Compositions and methods for the treatment of neurodegenerative and other diseases
摘要 In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine.
申请公布号 US9597339(B2) 申请公布日期 2017.03.21
申请号 US201414170405 申请日期 2014.01.31
申请人 GLIALOGIX, INC. 发明人 Reeder Thaddeus Cromwell;Moore Mark Wade;Lorenz Douglas Alan;Lyon David Keith
分类号 A61K31/635;A61K47/32;A61K9/16 主分类号 A61K31/635
代理机构 Hamilton DeSanctis & Cha, LLP 代理人 Nguyen Sam L.;Hamilton DeSanctis & Cha, LLP
主权项 1. A pharmaceutical composition comprising a solid dispersion of: sulfasalazine, in essentially amorphous form, and PVP VA64, having a ratio of sulfasalazine to PVP VA64 between about 20:80 wt./wt. to 30:70 wt./wt.
地址 San Anselmo CA US